|
Showing the most relevant articles for your search:NASDAQ:AVXS | Date | Time | Source | Headline | Symbol | Company | | 12/05/2017 | 6:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/05/2017 | 6:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 12/05/2017 | 6:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/13/2017 | 5:01PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/09/2017 | 4:15PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/09/2017 | 4:07PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/09/2017 | 4:00PM | GlobeNewswire Inc. | AveXis Reports Third Quarter 2017 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/03/2017 | 5:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/03/2017 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/02/2017 | 8:00AM | GlobeNewswire Inc. | AveXis to Report Third Quarter 2017 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/02/2017 | 6:04AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/01/2017 | 5:53PM | Dow Jones News | As Experimental Treatments Grow, Families Face Tough Choices | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 11/01/2017 | 5:13PM | Business Wire | AveXis Announces New England Journal of Medicine Publication of Phase 1 Data of AVXS-101 Gene Replacement Therapy in Spinal M... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/20/2017 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/20/2017 | 5:04PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/19/2017 | 4:59PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/11/2017 | 5:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/03/2017 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/03/2017 | 8:07AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 10/03/2017 | 8:00AM | GlobeNewswire Inc. | AveXis to Report Top-line Data from the Phase 1 Clinical Trial of AVXS-101 in SMA Type 1 at the International Annual Congress... | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/29/2017 | 7:11AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/29/2017 | 7:00AM | GlobeNewswire Inc. | AveXis Announces Plan to Initiate Pivotal Trial of AVXS-101 in SMA Type 1 Using Product from New GMP Commercial Process | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/19/2017 | 9:38AM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/08/2017 | 5:22PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 09/05/2017 | 5:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/22/2017 | 5:11PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/10/2017 | 4:14PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/10/2017 | 4:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/10/2017 | 4:01PM | GlobeNewswire Inc. | AveXis Reports Second Quarter 2017 Financial and Operating Results | NASDAQ:AVXS | Avexis, Inc. (delisted) |
| 08/03/2017 | 5:03PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVXS | Avexis, Inc. (delisted) |
|
Showing the most relevant articles for your search:NASDAQ:AVXS |
|